Details of Disease

General Information of Disease (ID: DISG0QYN)

• Disease Name: Peripheral nervous system tumour
• Synonyms: nerve sheath tumours; nerve sheath tumors; nerve sheath neoplasm; CNS-excluded nervous sys. cancer; tumour of the peripheral nervous system; tumour of the peripheral nerve; tumour of the PNS; tumour of peripheral nervous system; tumour of peripheral nerve; tumour of PNS; tumor of the peripheral nervous system; tumor of the peripheral nerve; tumor of the PNS; tumor of peripheral nervous system; tumor of peripheral nerve; tumor of PNS; peripheral nervous system tumour; peripheral nervous system tumor; peripheral nervous system neoplasm (disease); peripheral nervous system neoplasm; peripheral nerve tumour; peripheral nerve tumor; peripheral nerve neoplasm; neoplasms, peripheral nervous system; neoplasms, PNS; neoplasm of the peripheral nervous system; neoplasm of the peripheral nerve; neoplasm of the PNS; neoplasm of peripheral nervous system; neoplasm of peripheral nerve; neoplasm of PNS; PNS tumour; PNS tumor; PNS neoplasms; PNS neoplasm
• Disease Class: 2B5D-2B5Y: Malignant mesenchymal neoplasm
• Definition: A benign or malignant neoplasm arising from a peripheral nerve or the perineural sheaths.
• Disease Hierarchy:
  DISRUHOW: Peripheral nervous system disorder
  DISTBY9Z: Tumour
  DIS141UP: Nervous system neoplasm
  DISG0QYN: Peripheral nervous system tumour
• ICD Code: ICD-11: ICD-11: 2B5E
• Disease Identifiers:
  MONDO ID: MONDO_0001406
  MESH ID: D010524
  UMLS CUI: C0031118
  MedGen ID: 45817
  HPO ID: HP:0100007
  SNOMED CT ID: 126980002

Drug-Interaction Atlas (DIA) of This Disease

This Disease is Treated as An Indication in 1 Clinical Trial Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Imlygictalimogene laherparepvec	DMA17CT	Phase 1	NA	[1]

Molecular Interaction Atlas (MIA) of This Disease

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)